Pharmacogenetics and ethnically targeted therapies

BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7506.1508-a (Published 23 June 2005) Cite this as: BMJ 2005;330:1508

Racial drugs need to be put in context

  1. Jonathan D Kahn, assistant professor of law (jkahn01@hamline.edu)
  1. Hamline University School of Law, 1526 Hewitt Avenue, St Paul, MN 55104, USA

    EDITOR—Rahemtulla and Bhopal focus on the heart failure drug BiDil to explore the “resurgence of the role of biology in concepts of race and ethnicity.”1 BiDil, a combination of two generic drugs (hydralazine and isosorbide dinitrate) that have been used for years to treat heart failure, is currently undergoing review by the US Food and Drug Administration …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription